Peregrine Capital Management’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $7.82M | Sell |
|
|||||
|
2025
Q2 | $8.19M | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $1.21M | Buy |
|
|||||
|
2023
Q4 | $1.84M | Sell |
|
|||||
|
2023
Q3 | $2.4M | Sell |
|
|||||
|
2023
Q2 | $3.14M | Sell |
|
|||||
|
2023
Q1 | $4.13M | Buy |
|
|||||
|
2022
Q4 | $2.04M | Sell |
|
|||||
|
2022
Q3 | $1.99M | Sell |
|
|||||
|
2022
Q2 | $2.38M | Sell |
|
|||||
|
2022
Q1 | $4.42M | Sell |
|
|||||
|
2021
Q4 | $9.53M | Buy |
|
|||||
|
2021
Q3 | $9.43M | Sell |
|
|||||
|
2021
Q2 | $13.2M | Buy |
|
|||||
|
2021
Q1 | $11.4M | Sell |
|
|||||
|
2020
Q4 | $17.6M | Sell |
|
|||||
|
2020
Q3 | $15.9M | Sell |
|
|||||
|
2020
Q2 | $18M | Sell |
|
|||||
|
2020
Q1 | $10.7M | Buy |
|
|||||
|
2019
Q4 | $8.84M | Buy |
|